mygene_sep29_a4

PERSONALIZED GENOMIC ANALYSIS FOR

DISEASE PREDICTION

Introduced by Delancy’s © 2014

Personalized Genomic Analysis for Disease Prediction | 02

WHY DO YOU NEED A

PERSONALIZED GENOMIC ANALYSIS?

Why do you need a personalized Genomic Analysis | 03

REALIZATION OF ERSONALIZED MEDICINE

HEALTHY LIFE EXTENSION

M CHECK

DISEASE PREVENTION

You can lead healthier life by adopting an appropriate lifestyle and controlling the disease-causing environmental factors based on the genetic information related to disease occurrence.

SYSTEMATIC HEALTHCARE

PARADIGM SHIFT FROM DIAGNOSIS TO PREVENTION It is much better for a disease to be prevented through early prediction (before its onset) than for it to be treated when it has already occurred.

NEW ERA OF PERSONALIZED MEDICINE

An individual’s genetic characteristics must be identified to realize personalized medicine.

HEALTHY LIFE EXTENSION THROUGH HEALTHCARE It is necessary to have personalized healthcare through genome analysis for transition to a healthy life, determining not only how long one can live but also how one can lead a long and healthy life.

Personalized Genomic Analysis for Disease Prediction | 04

WHAT IS

PERSONALIZED GENOMIC ANALYSIS?

It is a next-generation personalized healthcare program that predicts the future risk of disease occurrence in a person through genome analysis, and that presents the direction of healthcare management based on the analysis results. It aims to analyze the genes related to the occurrence of a certain disease, such as a chronic disease or cancer, to predict a person’s disease susceptibility or risk.

What is personalized Genomic Analysis | 05

Report example (Report itself approximates 50-100 pages long & comes with a hard copy folder)

HOW CAN I USE IT? CHANGES IN EATING HABITS AND LIFESTYLES In the case of diseases that are greatly influenced by one’s eating habits and lifestyle, such as diabetes or colon cancer, guidelines will be presented to prevent the onset of such diseases, and the patient can consult the doctor(s) in charge.

APPLICATION OF WELLNESS CARE The genome analysis results can be used as basic data for keeping an appropriate diet-exercise-rest-medical diagnosis balance, beyond mere life extension, through prevention, care, and management before disease occurrence.

Personalized Genomic Analysis for Disease Prediction | 06

OUR STRENGTH PERSONALIZED ANALYSIS BY RACE Analysis suitable for each race can be done because we have the required database for such.

MANAGEMENT OF AN AFFILIATED RESEARCH INSTITUTE MEDIZEN HUMANCARE strives to constantly improve the quality of M-CHECK through continuous research at its affiliated research institute.

POSSESSION OF INDEPENDENT ANALYSIS ALGORITHMS MEDIZEN HUMANCARE provides more accurate analysis values through the unique analysis algorithm it developed based on research with genetic statisticians.

PROVISION OF PERSONALIZED HEALTH SOLUTIONS MEDIZEN HUMANCARE provides personalized health solutions in consultation with specialists based on the genome analysis results.

SECURITY OF PERSONAL INFORMATION The sample and genetic information of a customer who has completely consulted about his/her analysis results shall be discarded upon the client’s request, on the same day that the request is made. When a research consent form is accomplished, all samples and personal/genetic information shall automatically be retained and strictly managed through the leak prevention system.

Our strength and what we offer | 07

WHAT WE OFFER Cancer

Cardiovascular diseases

Endocrine diseases

Degenerative diseases

Autoimmune disease

Mental health disorders

Drug reactions

M1

M2

Male (10)

Female (10)

Male (22)

Female (22)

Lung Cancer

Lung Cancer

Liver Cancer

Colorectal Cancer

Stomach Cancer Colrectal Cancer Prostate Cancer Coronary Artery Disease Myocardial Infarction Artrial Fibrillation Stroke Cerebral Aneurysm

Breast Cancer Thyroid Cancer Cervical Cancer Coronary Artery Disease Myocardial Infarction Atrial Fibrillation Stroke Cerebral Aneurysm

Lung Cancer Liver Cancer Stomach Cancer Diffuse-Type Gastric Cancer Colrectal Cancer Pancreatic Cancer Bladder Cancer Esophageal Cancer Kidney Cancer Thyroid Cancer Prostate Cancer Acute Myeloid Leukemia Asthma Gout Psoriasis Systemic Lupus Erythematosus Atopic Dermatitis Ulcerative Colitis Chronic Hepatitis C Knee Osteoarthritis

Lung Cancer Liver Cancer Stomach Cancer Diffuse-Type Gastric Cancer Colorectal Cancer Pancreatic Cancer Bladder Cancer Breast Cancer Thyroid Cancer Cervical Cancer Endometrial Cancer Acute Myeloid Leukemia Asthma Gout Psoriasis Systemic Lupus Erythematosus Atopic Dermatitis Ulcerative Colitis Chronic Hepatitis C Knee Osteoarthritis

Rheumatoid Arthritis

Rheumatoid Arthritis

Rheumatic Heart Disease Rheumatic Heart Disease

Personalized Genomic Analysis for Disease Prediction | 08

M4

M3 Male (36)

Female (37)

Lung Cancer Lung Cancer Liver Cancer Liver Cancer Stomach Cancer Stomach Cancer Diffuse-Type Gastric Cancer Diffuse-Type Gastric Cancer Colrectal Cancer Colorectal Cancer Pancreatic Cancer Pancreatic Cancer Gallbladder Cancer Bladder Cancer Bladder Cancer Gallbladder Cancer Esophageal Cancer Breast Cancer Kidney Cancer Thyroid Cancer Thyroid Cancer Cervical Cancer Prostate Cancer Endometrial Cancer Acute Myeloid Leukemia Ovarian Cancer Asthma Acute Myeloid Leukemia Gout Asthma Psoriasis Gout Systemic Lupus Psoriasis Erythematosus Systemic Lupus Atopic Dermatitis Erythematosus Ulcerative Colitis Atopic Dermatitis Chronic Hepatitis C Ulcerative Colitis Knee Osteoarthritis Chronic Hepatitis C Rheumatoid Arthritis Knee Osteoarthritis Rheumatic Heart Disease Rheumatoid Arthritis Coronary Artery Disease Rheumatic Heart Disease Myocardial Infarction Coronary Artery Disease Atrial Fibrillation Myocardial Infarction Stroke Atrial Fibrillation Cerebral Aneurysm Stroke Glaucoma

Cerebral Aneurysm

Age-related Macular Degeneration

Glaucoma

Obesity Type 1 Diabetes Type 2 Diabetes Osteoporosis Hypertension Alzheimer’s Disease

Age-related Macular Degeneration Obesity Type 1 Diabetes Type 2 Diabetes Osteoporosis Hypertension Alzheimer’s Disease

Male (48)

Female (52)

Lung Cancer Liver Cancer Stomach Cancer Diffuse-Type Gastric Cancer Colrectal Cancer Pancreatic Cancer Gallbladder Cancer Bladder Cancer Esophageal Cancer Kidney Cancer Thyroid Cancer Prostate Cancer Acute Myeloid Leukemia Non-Hodgkin’s Lymphoma Asthma Gout Psoriasis Systemic Lupus Erythematosus Atopic Dermatitis Ulcerative Colitis

Lung Cancer Liver Cancer Stomach Cancer Diffuse-Type Gastric Cancer Colorectal Cancer Pancreatic Cancer Bladder Cancer Gallbladder Cancer Breast Cancer Thyroid Cancer Cervical Cancer Endometrial Cancer Ovarian Cancer Esophageal Cancer Kidney Cancer Acute Myeloid Leukemia Non-Hodgkin’s Lymphoma

Chronic Hepatitis C Knee Osteoarthritis Rheumatoid Arthritis Rheumatic Heart Disease Coronary Artery Disease Myocardial Infarction Atrial Fibrillation Stroke Cerebral Aneurysm Glaucoma Age-related Macular Degeneration Obesity Type 1 Diabetes Type 2 Diabetes Osteoporosis Hypertension Alzheimer’s Disease

Asthma Gout Psoriasis Systemic Lupus Erythematosus Atopic Dermatitis Ulcerative Colitis Chronic Hepatitis C Knee Osteoarthritis Rheumatoid Arthritis Rheumatic Heart Disease Coronary Artery Disease Myocardial Infarction Atrial Fibrillation Stroke Cerebral Aneurysm Glaucoma Age-related Macular Degeneration Obesity Type 1 Diabetes Type 2 Diabetes

What we offer and process of M-check | 09

PROCESS OF M-CHECK 1. The testee fills out and signs a test consent form (request form) 2. Saliva samples are collected from the testee and send it to the lab in Seoul, Korea.

3. DNA is extracted from the testee, and the testee’s genomes are analyzed.

4. Analysis results are drawn and delivered to you. (2-3 weeks).

5. The testee consults a specialist about the analysis results if needed.

M4 Male (48)

Female (52)

Parkinson’s Disease Osteoarthritis Lumber Herniated Intervertebral Disc Food Allergy Narcolepsy

Osteoporosis Hypertension

Depression Bi-Polar Disorder Schizophrenia Panic Disorder ADHD Autism

Alzheimer’s Disease Parkinson’s Disease Osteoarthritis Lumber Herniated Intervertebral Disc Gestational Diabetes Food Allergy Narcolepsy Depression Bi-Polar Disorder Schizophrenia Panic Disorder ADHD Autism

Personalized Genomic Analysis for Disease Prediction | 10

WHO ARE WE? MEDIZEN HUMANCARE is a trustworthy company leading the field of disease prediction, with unusual-disease-related gene contents and long-accumulated knowledge and skills related to result interpretation through disease genome research by race.

It is also a professional research institute that devotes itself to identifying disease-related gene contents and new-drug candidate genes, and to developing new disease prevention methods with the most advanced genome research techniques and analysis devices.

MEDIZEN HUMANCARE aims to establish a complete disease prediction system suitable for many different races through continuous genome analysis and research and the discovery of disease-related genes at its affiliated research institute, which acquired the certification of Korea Industrial Technology Association (KOITA).

The research team is composed of researchers specializing in medical science, genetics, molecular biology, biochemistry, statistics, bioinformatics, and clinical pathology.

Who are we | 11

Delancy’s Pte Ltd is Medizen Humancare’s strategic South Asian arm based in Singpaore. We aim to offer direct access to world class biotechnology in preventative and age-defying services in Seoul, Korea.

Introduced by Delancy’s © 2014

Level 25 One Raffles Quay North Tower, Singapore 048583 M: +65 8223 9030 T : +65 6622 5856 E: lauren.kim@delancysgroup.com